Table 3.

Clinical outcomes.

	Study population n = 407	Female n = 64	Male n = 343	p
Heart failure	50 (12.3%)	13 (20.3%)	37 (10.8%)	0.05
Worsening of HF	35/407 (8.6%)	7/64 (10.9%)	28/343 (8.2%)	0.62
Rehospitalization for HF	23/407 (5.7%)	9/64 (14.1%)	14/343 (4.1%)	0.005
Other outcomes
Death from any cause	1 (0.2%)	0 (0%)	1 (0.3%)	0.99
Cardiovascular death	1 (0.2%)	0 (0%)	1 (0.3%)	0.99
Recurrent myocardial infarction	13 (3.2%)	2 (3.1%)	11 (3.2%)	0.99
Stroke	7 (1.7%)	1 (1.6%)	6 (1.7%)	0.99
Cardiogenic shock	7 (1.7%)	0 (0%)	7 (2%)	0.60
Unstable angina	9 (2.2%)	2 (3.1%)	7 (2%)	0.63

The values are presented as no./total no. (%).